BI to co-host September's CamNTF at the Wellcome Genome Campus
The Babraham Institute is pleased to announce that it is co-hosting the next CamNTF at the Wellcome Genome Campus. Launched in 2015, CamNTF hosts early-evening meetings open to all scientists interested in research into new therapeutics. These rotate around different organisations located in the Cambridge biotech cluster. Each two-hour session will begin with short scientific presentations and will be followed by networking and snacks.
The next of these sessions will be held on 19 September.
All are welcome to attend for free but registration is required.
The purpose of Cambridge New Therapeutics Forum (CamNTF) is to promote interactions between scientists at these organisations in order to improve opportunities for biotechnology research and development. September's CamNTF will feature talks from Dr Michelle Linterman, group leader at the Babraham Institute; Prof. Sir Mike Stratton, director of the Sanger Institute and Dr Pedro Beltrao, Group leader at EMBL-EBI.
For more information, including a full programme and to register for free, click here. Registration closes midday 9 September.